Earnings Per Share

6 Months Ended

Jun. 30, 2026

Note 5 – Earnings Per Share

Basic and diluted earnings per share were computed as follows:


	Three Months Ended
	June 30, 2026						June 30, 2025
(Shares in thousands, dollars in millions, except per share amounts)	Basic		Effect of Dilution		Diluted		Basic		Effect of Dilution		Diluted
Shareholders' net income	$	1,660			$	1,660	$	1,532			$	1,532
Shares:
Weighted average	262,986				262,986		266,181				266,181
Common stock equivalents			976		976				1,973		1,973
Total shares	262,986		976		263,962		266,181		1,973		268,154
Earnings per share	$	6.31	$	(0.02)	$	6.29	$	5.76	$	(0.05)	$	5.71


	Six Months Ended
	June 30, 2026						June 30, 2025


(Shares in thousands, dollars in millions, except per share amounts)	Basic		Effect of Dilution		Diluted		Basic		Effect of Dilution		Diluted
Shareholders' net income	$	3,314			$	3,314	$	2,855			$	2,855
Shares:
Weighted average	262,867				262,867		268,511				268,511
Common stock equivalents			1,123		1,123				2,029		2,029
Total shares	262,867		1,123		263,990		268,511		2,029		270,540
Earnings per share	$	12.61	$	(0.06)	$	12.55	$	10.63	$	(0.08)	$	10.55

The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:


	Three Months Ended June 30,		Six Months Ended June 30,
(In millions)	2026	2025	2026	2025
Anti-dilutive options	2.2	1.5	2.3	1.9

On July 22, 2026, the Board of Directors of The Cigna Group (the "Board") declared the third quarter cash dividend of $1.56 per share of The Cigna Group common stock to be paid on September 23, 2026 to shareholders of record on September 8, 2026. The Company currently intends to pay regular quarterly dividends, with future declarations subject to approval by the Board and the Board's determination that the declaration of dividends remains in the best interests of The Cigna Group and its shareholders. The decision of whether to pay future dividends and the amount of any such dividends will be based on the Company's financial position, results of operations, cash flows, capital requirements, the requirements of applicable law and any other factors the Board may deem relevant.

The Company held approximately 142.3 million shares of common stock in treasury as of June 30, 2026, 141.1 million shares as of December 31, 2025 and 137.4 million shares as of June 30, 2025.

Cigna Group 10-Q